M-ZOLMITRIPTAN DIN 02566133
Health Canada record
| Active ingredient(s) | ZOLMITRIPTAN 2.5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N02CC03 ZOLMITRIPTAN |
| Original market date | 15-Jul-2026 |
| Current status date | 15-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mantra Pharma Inc. — licence 101740, currently licensed, last inspection rating C (2023-05-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ZOLMITRIPTAN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02481030 | AURO-ZOLMITRIPTAN | AURO PHARMA INC | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02512831 | BIO-ZOLMITRIPTAN | BIOMED PHARMA | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02398036 | IPG-ZOLMITRIPTAN | MARCAN PHARMACEUTICALS INC | Tablet | ZOLMITRIPTAN 2.5 MG | Approved |
| 02421623 | JAMP-ZOLMITRIPTAN | JAMP PHARMA CORPORATION | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02399458 | MAR-ZOLMITRIPTAN | MARCAN PHARMACEUTICALS INC | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02419521 | MINT-ZOLMITRIPTAN | MINT PHARMACEUTICALS INC | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02421534 | NAT-ZOLMITRIPTAN | NATCO PHARMA (CANADA) INC | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02489392 | NRA-ZOLMITRIPTAN | NORA PHARMA INC | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02362988 | SANDOZ ZOLMITRIPTAN | SANDOZ CANADA INCORPORATED | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02362996 | SANDOZ ZOLMITRIPTAN ODT | SANDOZ CANADA INCORPORATED | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02313960 | TEVA-ZOLMITRIPTAN | TEVA CANADA LIMITED | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02342545 | TEVA-ZOLMITRIPTAN OD | TEVA CANADA LIMITED | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02418924 | ZOLMITRIPTAN | JUBILANT GENERICS LIMITED | Tablet | ZOLMITRIPTAN 2.5 MG | Approved |
| 02546833 | ZOLMITRIPTAN | SIVEM PHARMACEUTICALS ULC | Tablet | ZOLMITRIPTAN 2.5 MG | Approved |
| 02546841 | ZOLMITRIPTAN ODT | SIVEM PHARMACEUTICALS ULC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Approved |
| 02419440 | ZOLMITRIPTAN-ODT | JUBILANT GENERICS LIMITED | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Approved |
| 02238660 | ZOMIG | XEDITON PHARMACEUTICALS INC | Tablet | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02248992 | ZOMIG NASAL SPRAY | XEDITON PHARMACEUTICALS INC | Spray | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02248993 | ZOMIG NASAL SPRAY | XEDITON PHARMACEUTICALS INC | Spray | ZOLMITRIPTAN 5 MG | Marketed |
| 02243045 | ZOMIG RAPIMELT | XEDITON PHARMACEUTICALS INC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Marketed |
| 02438453 | AG-ZOLMITRIPTAN ODT | ANGITA PHARMA INC. | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02380951 | APO-ZOLMITRIPTAN | APOTEX INC | Tablet | ZOLMITRIPTAN 2.5 MG | Dormant |
| 02381575 | APO-ZOLMITRIPTAN RAPID | APOTEX INC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Dormant |
| 02458780 | CCP-ZOLMITRIPTAN | CELLCHEM PHARMACEUTICALS INC. | Tablet | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02389525 | DOM-ZOLMITRIPTAN | DOMINION PHARMACAL | Tablet | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02389533 | DOM-ZOLMITRIPTAN ODT | DOMINION PHARMACAL | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Pre Market |
| 02477106 | JAMP ZOLMITRIPTAN | JAMP PHARMA CORPORATION | Tablet | ZOLMITRIPTAN 2.5 MG | Dormant |
| 02428237 | JAMP-ZOLMITRIPTAN ODT | JAMP PHARMA CORPORATION | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Dormant |
| 02419513 | MINT-ZOLMITRIPTAN ODT | MINT PHARMACEUTICALS INC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02369036 | MYLAN-ZOLMITRIPTAN | MYLAN PHARMACEUTICALS ULC | Tablet | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02387158 | MYLAN-ZOLMITRIPTAN ODT | MYLAN PHARMACEUTICALS ULC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02324229 | PMS-ZOLMITRIPTAN | PHARMASCIENCE INC | Tablet | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02324768 | PMS-ZOLMITRIPTAN ODT | PHARMASCIENCE INC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02338041 | RATIO-ZOLMITRIPTAN IR | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Immediate-Release) | ZOLMITRIPTAN 2.5 MG | Cancelled Pre Market |
| 02340313 | RATIO-ZOLMITRIPTAN ODT | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Pre Market |
| 02401304 | RIVA-ZOLMITRIPTAN | LABORATOIRE RIVA INC. | Tablet | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02428474 | SEPTA-ZOLMITRIPTAN-ODT | SEPTA PHARMACEUTICALS INC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Dormant |
| 02313952 | TEVA-ZOLMITRIPTAN | TEVA CANADA LIMITED | Tablet | ZOLMITRIPTAN 1.0 MG | Cancelled Pre Market |
| 02342553 | TEVA-ZOLMITRIPTAN OD | TEVA CANADA LIMITED | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 1 MG | Cancelled Pre Market |
| 02438771 | VAN-ZOLMITRIPTAN | VANC PHARMACEUTICALS INC | Tablet | ZOLMITRIPTAN 2.5 MG | Cancelled Pre Market |
| 02438763 | VAN-ZOLMITRIPTAN ODT | VANC PHARMACEUTICALS INC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02442655 | ZOLMITRIPTAN | SANIS HEALTH INC | Tablet | ZOLMITRIPTAN 2.5 MG | Dormant |
| 02379929 | ZOLMITRIPTAN | PRO DOC LIMITEE | Tablet | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
| 02442671 | ZOLMITRIPTAN ODT | SANIS HEALTH INC | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Dormant |
| 02379988 | ZOLMITRIPTAN ODT | PRO DOC LIMITEE | Tablet (Orally-Disintegrating) | ZOLMITRIPTAN 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36974 | 2026-02-25 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for ZOLMITRIPTAN
3 valid EDQM Certificates of Suitability from 3 holders. 17 active FDA Drug Master Files.
Request a quote for M-ZOLMITRIPTAN